Charlie's Holdings, Inc. (CHUC)
CHUC is quoted over the counter, not listed on an exchange. Charlie's Holdings, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | CHUC, quoted over the counter |
| SEC CIK | 0001134765 |
| OTC Markets tier | OTCQB (price source, 2026-11-13) |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Business address | Costa Mesa, CA |
| Incorporated in | NV |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. "Management evaluated whether these conditions could raise a substantial doubt about the Company's ability to continue as a going concern." | 10-Q 2026-08-17 |
| Cash and burn | $527K cash; operating cash flow -$1.1M a quarter. | Report 2026-06-30 |
| Shares outstanding | 280,553,242 (2026-08-17); 262,434,864 a year earlier; 224,622,552 three years earlier. | Cover page 2026-08-17 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Urish Popeck & Company, LLC, Pittsburgh, Pennsylvania, United States | PCAOB Form AP 2026-04-02 |
| Late filings, 12 months | 4 NT notices | NT 10-Q 2026-11-13 |
| Insider trades, 12 months | Bought $219K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $3.8M | -$1.7M | -$383K | $527K | No debt tags | $24.7M | 10-Q 2026-08-17 |
| Q1 2026 2026-03-31 | $4.8M | -$1.1M | -$1.1M | $640K | No debt tags | $22.6M | 10-Q 2026-05-20 |
| Q4 2025 2025-12-31 | $9.0M | $131K | $394K | $1.3M | No debt tags | $19.4M | 10-K 2026-04-01 |
| Q3 2025 2025-09-30 | $7.1M | $624K | -$3.1M | $1.1M | No debt tags | $11.5M | 10-Q 2025-11-19 |
| Q2 2025 2025-06-30 | $1.8M | $5.0M | -$2.7M | $1.5M | No debt tags | $6.0M | 10-Q 2026-08-17 |
| Q1 2025 2025-03-31 | $1.6M | -$1.2M | -$409K | $112K | $3.1M | $6.3M | 10-Q 2026-05-20 |
| Q4 2024 2024-12-31 | $1.0M | -$1.1M | -$377K | $211K | $2.2M | $7.8M | 10-K 2026-04-01 |
| Q3 2024 2024-09-30 | $1.6M | -$1.0M | -$944K | $601K | $2.6M | $12.3M | 10-Q 2025-11-19 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2020-02-20 |
| Latest annual report | 10-K | 2026-04-01 |
| Latest quarterly / interim | 10-Q | 2026-08-17 |
| Latest current report | 8-K | 2026-08-04 |
| Latest proxy | DEF 14A | 2026-04-20 |
Source: SEC EDGAR submissions feed, 821 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier